New Study Shows Cannabis Is Needed More Than Ever Since The Pandemic
1.5 min readPublished On: April 1st, 2021By News Team
NEW YORK–Interesting new survey data collected by cannabis media outlet WayofLeaf suggests that medical cannabis is in heightened demand, despite increased access to recreational cannabis via adult-use laws.
Results of the study highlight that 70% of potential MMJ card applicants needed cannabis “more in the past 12 months” compared to other years. This suggests an obvious correlation between the impact of the coronavirus pandemic and the ongoing need for medicinal cannabis access.
In fact, according to the survey, nearly 1-in-3 MMJ card applicants (or potential applicants) say they are interested in medical marijuana use to help relieve anxiety and stress. A further 71% of survey participants said they would prefer to use medical cannabis under the guidance of a doctor, rather than on their own.
“The survey data is interesting, to say the least,” says WayofLeaf Content Director Dylan Baker. “It’s clear the pandemic has produced heightened levels of stress and anxiety, and far more people than we expected are looking to medical cannabis as a potential outlet for relief.”
The conducted survey and corresponding data were collected internally by WayofLeaf. Additional highlights from the survey include the fact that 85% of participants felt “confident or very confident” that medical cannabis could help with their specific condition. However, less than half said they were satisfied with current MMJ card application processes.
“For us, there were three key takeaways from the survey,” Baker says. “People have stress and anxiety from the pandemic, they’re wanting to use doctor-guided cannabis to cope, but they’re not satisfied with current MMJ card application processes in their state.”
In addition to highlighting results of the survey, the WayofLeaf team pointed out recommended avenues MMJ card applicants can use to connect to doctors online, rather than having to go through costly and time-consuming in-person application processes.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Pharmaceuticals Inc. announced today the peer-reviewed publication of its sponsored preclinical study titled "The Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue" in the International Journal of Molecular Sciences; concluding "possible future therapeutic value" for the ...
LAS VEGAS, Sept. 29, 2022 Hippo Premium Packaging a provider of custom packaging and branding solutions to the cannabis and hemp industries, specializes in designing beautiful custom packaging for the cannabis and hemp industries. The ...
LANSING, Mich., Sept. 28, 2022 ACT Laboratories, Inc. a testing company in the legal cannabis and hemp markets, today announced an agreement to acquire CDX Analytics, LLC ("CDX") of Massachusetts "ACT Labs is out to build the foremost, ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more